Abbott India Limited (ABBOTINDIA.BO)

INR 28764.0

(2.24%)

Long Term Debt Summary of Abbott India Limited

Abbott India Limited's latest annual long term debt in 2023 was 367.6 Million INR , down -45.53% from previous year.
Abbott India Limited's latest quarterly long term debt in 2023 FY was 367.6 Million INR , down -45.53% from previous quarter.
Abbott India Limited reported annual long term debt of 674.9 Million INR in 2022, down -37.93% from previous year.
Abbott India Limited reported annual long term debt of 1.08 Billion INR in 2021, down -7.6% from previous year.
Abbott India Limited reported quarterly long term debt of 451.4 Million INR for 2023 Q2, down 0.0% from previous quarter.
Abbott India Limited reported quarterly long term debt of 367.6 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Abbott India Limited (2023 - 2004)

Historical Annual Long Term Debt of Abbott India Limited (2023 - 2004)

Year	Long Term Debt	Long Term Debt Growth
2023	367.6 Million INR	-45.53%
2022	674.9 Million INR	-37.93%
2021	1.08 Billion INR	-7.6%
2020	1.17 Billion INR	-15.46%
2019	1.39 Billion INR	0.0%
2018	- INR	0.0%
2017	- INR	0.0%
2016	- INR	0.0%
2015	- INR	0.0%
2014	- INR	0.0%
2013	- INR	0.0%
2012	- INR	0.0%
2011	- INR	0.0%
2010	- INR	0.0%
2009	- INR	-100.0%
2008	7.6 Million INR	-26.21%
2007	10.3 Million INR	-26.95%
2006	14.1 Million INR	-22.53%
2005	18.2 Million INR	-16.89%
2004	21.9 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q3	- INR	-100.0%
2023 Q2	451.4 Million INR	0.0%
2023 Q4	367.6 Million INR	0.0%
2023 FY	367.6 Million INR	-45.53%
2023 Q1	- INR	-100.0%
2022 Q4	674.9 Million INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q2	856.5 Million INR	0.0%
2022 FY	674.9 Million INR	-37.93%
2022 Q3	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 FY	1.08 Billion INR	-7.6%
2021 Q1	- INR	-100.0%
2021 Q4	1.08 Billion INR	0.0%
2021 Q2	1.2 Billion INR	0.0%
2020 Q4	1.17 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 Q2	1.31 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2020 FY	1.17 Billion INR	-15.46%
2019 Q3	- INR	-100.0%
2019 Q2	253.1 Million INR	0.0%
2019 Q1	- INR	0.0%
2019 FY	1.39 Billion INR	0.0%
2019 Q4	1.39 Billion INR	0.0%
2018 Q3	- INR	0.0%
2018 FY	- INR	0.0%
2018 Q4	- INR	0.0%
2018 Q2	- INR	0.0%
2018 Q1	- INR	0.0%
2017 Q3	- INR	0.0%
2017 Q2	- INR	0.0%
2017 Q1	- INR	0.0%
2017 FY	- INR	0.0%
2017 Q4	- INR	0.0%
2016 Q3	- INR	0.0%
2016 Q4	- INR	0.0%
2016 Q2	- INR	0.0%
2016 FY	- INR	0.0%
2016 Q1	- INR	0.0%
2015 Q2	- INR	0.0%
2015 Q1	- INR	0.0%
2015 Q4	- INR	0.0%
2015 Q3	- INR	0.0%
2015 FY	- INR	0.0%
2014 Q1	- INR	0.0%
2014 FY	- INR	0.0%
2014 Q3	- INR	0.0%
2014 Q2	- INR	0.0%
2014 Q4	- INR	0.0%
2013 Q4	- INR	0.0%
2013 FY	- INR	0.0%
2013 Q2	- INR	0.0%
2013 Q1	- INR	0.0%
2012 Q4	- INR	0.0%
2012 FY	- INR	0.0%
2012 Q3	- INR	0.0%
2011 FY	- INR	0.0%
2011 Q3	- INR	0.0%
2010 FY	- INR	0.0%
2009 FY	- INR	-100.0%
2008 FY	7.6 Million INR	-26.21%
2007 FY	10.3 Million INR	-26.95%
2006 FY	14.1 Million INR	-22.53%
2005 FY	18.2 Million INR	-16.89%
2004 FY	21.9 Million INR	0.0%

Peer Long Term Debt Comparison of Abbott India Limited

Name	Long Term Debt	Long Term Debt Difference
Cipla Limited	2.25 Billion INR	83.693%
Gland Pharma Limited	1.06 Billion INR	65.497%
GlaxoSmithKline Pharmaceuticals Limited	64.69 Million INR	-468.24%
Kopran Limited	166.02 Million INR	-121.41%
Marksans Pharma Limited	1.9 Billion INR	80.655%
NGL Fine-Chem Limited	7.44 Million INR	-4835.553%
Pfizer Limited	543.5 Million INR	32.364%
Sanofi India Limited	139 Million INR	-164.46%
SMS Pharmaceuticals Limited	1.22 Billion INR	69.89%